Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-04-11
DOI
10.1002/med.21498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody
- (2018) Sabrina Oliveira et al. Molecular Imaging
- Long-term direct visualization of passively transferred fluorophore-conjugated antibodies
- (2017) Jeffrey R. Schneider et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery
- (2017) Pieterjan Debie et al. MOLECULAR PHARMACEUTICS
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- EpCAM as multi-tumour target for near-infrared fluorescence guided surgery
- (2016) P. B. A. A. van Driel et al. BMC CANCER
- Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
- (2016) Laetitia E. Lamberts et al. CLINICAL CANCER RESEARCH
- Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM
- (2016) F. J. Warnders et al. JOURNAL OF NUCLEAR MEDICINE
- Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeutics
- (2016) Maria Myzithras et al. mAbs
- Effect of charge localization on the in vivo optical imaging properties of near-infrared cyanine dye/monoclonal antibody conjugates
- (2016) Kazuhide Sato et al. Molecular BioSystems
- Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody
- (2016) Simona Cignetto et al. Molecular Oncology
- Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy
- (2016) Hisataka Kobayashi et al. Nanoscale
- Standing out from the crowd
- (2016) Yichao Huang et al. Nature Chemistry
- Recent advances in the construction of antibody–drug conjugates
- (2016) Vijay Chudasama et al. Nature Chemistry
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers
- (2016) Ingrid J. G. Burvenich et al. EJNMMI Research
- Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
- (2016) Murli Krishna et al. Frontiers in Immunology
- Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes
- (2015) Anders E. Hansen et al. ACS Nano
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- Antibody–Drug Conjugates for Tumor Targeting—Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins
- (2015) Hannes Merten et al. BIOCONJUGATE CHEMISTRY
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
- (2015) Eunhee G. Kim et al. Biomolecules & Therapeutics
- A Polymer-Based Antibody-Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy
- (2015) A. V. Yurkovetskiy et al. CANCER RESEARCH
- ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment
- (2015) L. E. Lamberts et al. CLINICAL CANCER RESEARCH
- Challenges and opportunities for non-antibody scaffold drugs
- (2015) Rodrigo Vazquez-Lombardi et al. DRUG DISCOVERY TODAY
- Emerging formats for next-generation antibody drug conjugates
- (2015) Mahendra P Deonarain et al. Expert Opinion on Drug Discovery
- Molecular Imaging As a Tool for Drug Development and Trial Design
- (2015) Elisabeth G.E. de Vries et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
- (2015) Laetitia E. Lamberts et al. JOURNAL OF CLINICAL ONCOLOGY
- 89Zr-Labeled Versus 124I-Labeled HER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo
- (2015) C. T. Mendler et al. JOURNAL OF NUCLEAR MEDICINE
- Abstract A85: Preclinical evaluation of the radiolabeled bispecific T-cell engager 89Zr-AMG 211 targeting CEA-positive tumors
- (2015) S.J.H. Waaijer et al. MOLECULAR CANCER THERAPEUTICS
- In vivo imaging with antibodies and engineered fragments
- (2015) Amanda C. Freise et al. MOLECULAR IMMUNOLOGY
- Impact of C4′-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates
- (2015) Kazuhide Sato et al. MOLECULAR PHARMACEUTICS
- Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
- (2015) Robert P Lyon et al. NATURE BIOTECHNOLOGY
- Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer
- (2015) Jacob L. Houghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-immunoglobulin scaffolds: a focus on their targets
- (2015) Katja Škrlec et al. TRENDS IN BIOTECHNOLOGY
- Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with 89Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts
- (2015) Eva J. ter Weele et al. Oncotarget
- Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics
- (2015) Kine Marita Knudsen Sand et al. Frontiers in Immunology
- Optimization of Dual-Labeled Antibodies for Targeted Intraoperative Imaging of Tumors
- (2015) Mark Rijpkema et al. Molecular Imaging
- Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200
- (2015) Sture Lindegren et al. PLoS One
- Chemoenzymatic Strategy for the Synthesis of Site-Specifically Labeled Immunoconjugates for Multimodal PET and Optical Imaging
- (2014) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload
- (2014) Yilma T. Adem et al. BIOCONJUGATE CHEMISTRY
- Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging
- (2014) Sam Massa et al. BIOCONJUGATE CHEMISTRY
- Site-Specific Antibody–Drug Conjugation through Glycoengineering
- (2014) Qun Zhou et al. BIOCONJUGATE CHEMISTRY
- Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes
- (2014) Penelope M. Drake et al. BIOCONJUGATE CHEMISTRY
- Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling
- (2014) R. Cohen et al. CANCER RESEARCH
- Minimization of self-quenching fluorescence on dyes conjugated to biomolecules with multiple labeling sites via asymmetrically charged NIR fluorophores
- (2014) Natalia G. Zhegalova et al. Contrast Media & Molecular Imaging
- Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution
- (2014) VLADIMIR TOLMACHEV et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding
- (2014) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin 89Zr-PRS-110 PET Tracer
- (2014) A. G. T. Terwisscha van Scheltinga et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody
- (2014) S. M. Knowles et al. JOURNAL OF NUCLEAR MEDICINE
- First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
- (2014) J. Sorensen et al. JOURNAL OF NUCLEAR MEDICINE
- ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody89Zr-RG7116
- (2014) Anton GT Terwisscha van Scheltinga et al. mAbs
- Quantitative cumulative biodistribution of antibodies in mice
- (2014) Victor Yip et al. mAbs
- IND-Directed Safety and Biodistribution Study of Intravenously Injected Cetuximab-IRDye800 in Cynomolgus Macaques
- (2014) Kurt R. Zinn et al. MOLECULAR IMAGING AND BIOLOGY
- Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts
- (2014) Bernadette V. Marquez et al. MOLECULAR PHARMACEUTICS
- Why Are We Failing to Implement Imaging Studies with Radiolabelled New Molecular Entities in Early Oncology Drug Development?
- (2014) Azeem Saleem et al. TheScientificWorldJOURNAL
- Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes
- (2014) Jennifer L. Rojko et al. TOXICOLOGIC PATHOLOGY
- A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
- (2013) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Site Specific Discrete PEGylation of 124I-Labeled mCC49 Fab′ Fragments Improves Tumor MicroPET/CT Imaging in Mice
- (2013) Haiming Ding et al. BIOCONJUGATE CHEMISTRY
- ImmunoPET Imaging of Renal Cell Carcinoma with 124I- and 89Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
- (2013) Alexander B. Stillebroer et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- RG7116, a Therapeutic Antibody That Binds the Inactive HER3 Receptor and Is Optimized for Immune Effector Activation
- (2013) C. Mirschberger et al. CANCER RESEARCH
- Glycosylation: impact, control and improvement during therapeutic protein production
- (2013) Ana Rita Costa et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery
- (2013) Marta Kijanka et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency
- (2013) Jamie L. Betker et al. JOURNAL OF CONTROLLED RELEASE
- HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules
- (2013) Camilla Hofström et al. JOURNAL OF MEDICINAL CHEMISTRY
- 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer
- (2013) S. B. M. Gaykema et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of Colorectal and Breast Cancer by Targeting EphB4 Receptor with 64Cu-Labeled hAb47 and hAb131 Antibodies
- (2013) S. Liu et al. JOURNAL OF NUCLEAR MEDICINE
- Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
- (2013) Peter J.K. van Meer et al. mAbs
- A Highly Potent and Specific MET Therapeutic Protein Antagonist with Both Ligand-Dependent and Ligand-Independent Activity
- (2013) Shane A. Olwill et al. MOLECULAR CANCER THERAPEUTICS
- Targeted zwitterionic near-infrared fluorophores for improved optical imaging
- (2013) Hak Soo Choi et al. NATURE BIOTECHNOLOGY
- Phase I trial of intraoperative detection of tumor margins in patients with HER2-positive carcinoma of the breast following administration of 111In-DTPA-trastuzumab Fab fragments
- (2013) Claire M.B. Holloway et al. NUCLEAR MEDICINE AND BIOLOGY
- Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts
- (2013) Joanna Strand et al. PLoS One
- First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors
- (2013) Klaus Mross et al. PLoS One
- PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
- (2013) M. Schlapschy et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Questioning the use of PEGylation for drug delivery
- (2013) Johan J. F. Verhoef et al. Drug Delivery and Translational Research
- ADME of Antibody–Maytansinoid Conjugates
- (2012) Hans K. Erickson et al. AAPS Journal
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- Pharmacokinetic, Biodistribution, and Biophysical Profiles of TNF Nanobodies Conjugated to Linear or Branched Poly(ethylene glycol)
- (2012) Yulia Vugmeyster et al. BIOCONJUGATE CHEMISTRY
- 177Lu–DO3A–HSA–ZEGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas
- (2012) Susan Hoppmann et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition
- (2012) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of expression system on the function of the C6.5 diabody PET radiotracer
- (2012) Joshua Miller et al. TUMOR BIOLOGY
- Radiolabeled Affibody−Albumin Bioconjugates forHER2-Positive Cancer Targeting
- (2011) Susan Hoppmann et al. BIOCONJUGATE CHEMISTRY
- Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats
- (2011) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- HER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors
- (2011) R. Zielinski et al. CLINICAL CANCER RESEARCH
- Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin
- (2011) A. W. Tolcher et al. CLINICAL CANCER RESEARCH
- Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts
- (2011) Jennie Malmberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
- (2011) H. Wallberg et al. JOURNAL OF NUCLEAR MEDICINE
- Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4
- (2011) Daniela Bumbaca et al. mAbs
- Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
- (2011) Weirong Wang et al. MOLECULAR IMMUNOLOGY
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
- (2011) Gooitzen M van Dam et al. NATURE MEDICINE
- Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
- (2011) Makoto Mitsunaga et al. NATURE MEDICINE
- Evaluation of 111In labeled antibodies for SPECT imaging of mesothelin expressing tumors
- (2011) Ripen Misri et al. NUCLEAR MEDICINE AND BIOLOGY
- Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody
- (2011) In Soo Shin et al. NUCLEAR MEDICINE AND BIOLOGY
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
- (2011) Ruth Cohen et al. EJNMMI Research
- HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation
- (2010) Vladimir Tolmachev et al. BIOCONJUGATE CHEMISTRY
- Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
- (2010) C. Zahnd et al. CANCER RESEARCH
- Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
- (2010) Lea Olive Tchouate Gainkam et al. Contrast Media & Molecular Imaging
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT
- (2010) I. Vaneycken et al. JOURNAL OF NUCLEAR MEDICINE
- Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
- (2010) E. Vegt et al. JOURNAL OF NUCLEAR MEDICINE
- Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands
- (2010) Marc Hens et al. NUCLEAR MEDICINE AND BIOLOGY
- Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection
- (2010) Vijay Kumar et al. NUCLEAR MEDICINE AND BIOLOGY
- Distribution and Dynamics of 99mTc-Pertechnetate Uptake in the Thyroid and Other Organs Assessed by Single-Photon Emission Computed Tomography in Living Mice
- (2010) Philippe R. Franken et al. THYROID
- Phase I Biodistribution and Pharmacokinetic Study of Lewis Y-Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers
- (2009) R. A. Herbertson et al. CLINICAL CANCER RESEARCH
- Pharmacological significance of glycosylation in therapeutic proteins
- (2009) Huijuan Li et al. CURRENT OPINION IN BIOTECHNOLOGY
- p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
- (2009) Lars R. Perk et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives
- (2009) Roland Stork et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
- (2009) S. Ahlgren et al. JOURNAL OF NUCLEAR MEDICINE
- A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
- (2009) Volker Schellenberger et al. NATURE BIOTECHNOLOGY
- Emerging methods for the production of homogeneous human glycoproteins
- (2009) Jamie R Rich et al. Nature Chemical Biology
- A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution
- (2009) Fares Al-Ejeh et al. NUCLEAR MEDICINE AND BIOLOGY
- Receptor-mediated endocytosis in renal proximal tubule
- (2009) Erik Ilsø Christensen et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application
- (2009) Doreen M. Floss et al. TRENDS IN BIOTECHNOLOGY
- Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins
- (2008) Hiromichi Akizawa et al. ADVANCED DRUG DELIVERY REVIEWS
- Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of99mTc-Labeled Anti-HER2 Affibody Molecules
- (2008) Thuy A. Tran et al. BIOCONJUGATE CHEMISTRY
- N-Glycosylation as Novel Strategy to Improve Pharmacokinetic Properties of Bispecific Single-chain Diabodies
- (2008) Roland Stork et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- Anti-CD30 diabody-drug conjugates with potent antitumor activity
- (2008) K. M. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms for copper acquisition, distribution and regulation
- (2008) Byung-Eun Kim et al. Nature Chemical Biology
- Biodistribution and tumor imaging of an anti-CEA single-chain antibody–albumin fusion protein
- (2008) Paul J. Yazaki et al. NUCLEAR MEDICINE AND BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More